Nanjing Pharma: Plans to Invest No More Than 450 Million Yuan to Set Up M&A Fund to Specially Acquire Shares in Daqing Bio and Kejian Technology
BYD has officially denied rumors of considering an acquisition of Maserati. The company's executive vice president had previously mentioned exploring high-end European assets, including Maserati, and engaging in discussions with Stellantis Group about acquiring idle production facilities in Europe. BYD clarified that while they are evaluating potential acquisitions or investments in European luxury brands, there is no current plan to purchase Maserati. AI